Clinical Trial Details
EORTC-30971
Back to Clinical Trials Database
A feasibility study of thorough transurethral resection (TURB) and escalated dose M-VAC Chemotherapy as primary treatment of T2-T3a, N0-Nx, M0, transitional cell carcinoma of the bladder, with the intention of bladder preservation.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 17-Sep-1998 Date Step1 close: 20-Nov-2000 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 73 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00003640 |
| NCT number | NCT00003640 |
